So proud of the personalized cancer vaccine team at #Moderna! The data presented at #AACR2023 of the Phase II randomized #mRNA4157 vaccine + pembrolizumab trial in high-risk adjuvant melanoma are extremely promising.
@adamfeuerstein Thanks for this excellent analysis of a serious problem. Ideally, publishers, meeting administrators, regulators and companies should get together to come up with new criteria that all can agree on and abide by
This clip, from Larry David's new show "Life, Larry, and the Pursuit of Unhappiness" is one of his FUNNIEST ever.
Awesome to have Rob Reiner as George Washington in possibly one of his final on-screen performances.
Cameo by Kimmel is chef's kiss.
RIP, Rob Reiner.
Pfizer and Moderna CEOs should do a few town halls around the country with the public, explain the data behind mRNA and more, why it would be beneath our great country to turn anti-science, and allow regular people to ask them questions. You're welcome for the idea.💡
Thanks @CNN for bringing the play “Good Luck, and Good Night” to viewers around the globe tonite! Celebrating the strength of speaking truth to power, then, today and tomorrow!
The Melanoma Research Alliance mourns the passing of Dr. Jeffrey S. Weber, a pioneer in cancer immunotherapy. His groundbreaking work has forever changed melanoma treatment, bringing hope to countless patients. We extend our deepest condolences to his family, friends, colleagues, and patients. #MelanomaResearch #CancerResearch
A potential disaster for patients with cancer if such a major budget cut happens. Cancer clinicians and researchers need to speak up in all ways possible on behalf of our patients.
The American Heart Association guidelines for HCM treatment have just been updated for 2024. Cynthia Burstein Waldman @Cynaburst does a great job of breaking down the changes for you in this article from her blog HCMbeat: https://t.co/sEk7PpL7zk
@oledoteth Frankly, you didn’t visit average America. NYC is where you make the money and Las Vegas is where one goes to spend it. Two extreme locales. try the Pacific Northwest, or suburban areas around NYC, Boston, Washington, DC , Chicago or Dallas if you want to see the real US.
@JacobPlieth My point is that most small companies don’t have the cash, or will to setup programs before their first indication shows efficacy with DOR. If post Lorbena fails, going head to head in first line is something they can’t afford alone, and it’s a hard sell as a takeover target.